Gateway Blog

Gateway Blog

Personalized Medicine Succeeds in Helping Women Decide For or Against Chemotherapy

By Admin at 7 Nov 2016

A genetic test known as the 21-gene recurrence score assay (RS) measures the activity of genes that control cell growth and more. A high score on the test indicates a woman has a high risk of cancer recurrence and chemotherapy is recommended. A low score suggests chemotherapy can safely be skipped.

0 comments posted

    Categories

    Archive

    2018 2017 2016 2015
    99 cents of every dollar received directly funds cancer clinical trials

    58

    Current Gateway-funded clinical trials

    150+

    Clinical trials funded at leading institutions worldwide

    $16.56

    Funds one patient for one day at a Gateway-funded clinical trial

     
     

    Mission Partners